Clinical Trials at Duke Comprehensive Cancer Center

If you need additional information about any of the trials listed or would like to inquire about other open trials, please contact Donna Adams, RN at (919) 668-4716 for leukemia trials. For information on Myeloma trials call Catherine Sellers, RN (919)668-6524.

Trial Phase Leukemia and multiple myeloma
00007306 III CLO34100405: A Phase III Randomized, Double-Blind, Controlled Study Comparing Clofarabine and Cytarabine versus Cytarabine Alone in Adult Subjects 55 Years and Older with Acute Myelogenous Leukemia (AML) who have Relapsed or are Refractory after Receiv
00008662 I/II Phase I/II Study of Arsenic Trioxide (Trisenoxr). Ascorbic Acid and Bortezomib (Velcade r) Combination Therapy in Patients with Relapsed/Refractory Multiple Myeloma
00007995 I Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus Transplantation
00008151 II Phase II Trial of Sorafenib in Patients with Myelodysplastic Syndrome
00011792 II A Pilot Phase II Study of Decitabine, Arsenic Trioxide and Asorbic Acid for Patients with Myelodysplastic Syndrome
Duke Comprehensive Cancer Center Accolades